Tumor BRCA1, RRM1 and RRM2 mRNA Expression Levels and Clinical Response to First-Line Gemcitabine plus Docetaxel in Non-Small-Cell Lung Cancer Patients

BACKGROUND: Overexpression of RRM1 and RRM2 has been associated with gemcitabine resistance. BRCA1 overexpression increases sensitivity to paclitaxel and docetaxel. We have retrospectively examined the effect of RRM1, RRM2 and BRCA1 expression on outcome to gemcitabine plus docetaxel in advanced non...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Boukovinas, Ioannis, Papadaki, Chara, Mendez, Pedro, Taron, Miquel, Mavroudis, Dimitris, Koutsopoulos, Anastasios, Sanchez-Ronco, Maria, Sanchez, Jose Javier, Trypaki, Maria, Staphopoulos, Eustathios, Georgoulias, Vassilis, Rosell, Rafael, Souglakos, John
Format: Artigo
Idioma:Inglês
Publicat: Public Library of Science 2008
Matèries:
Research Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2579656/
https://ncbi.nlm.nih.gov/pubmed/19002265
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0003695
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars